bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 26 citations · 17 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryStructure-activity RelationshipsVirologyAntiviral PharmacologyLigand BindingMedicinal PlantsMolecular DockingProtein-ligand DockingStructure-activity Relationship AnalysisAntiviral Structure-activity RelationshipsBinding Affinity AssessmentMolecular Docking AnalysisMolecular Docking ValidationProtein TargetsSars-cov-2 InfectionViral GlycoproteinsVirtual Screening Validation
Abstract COV spike (S) glycoprotein and M pro are two key targets that have been identified for vaccines and drug development against the COVID-19 disease. Virtual screening of some compounds of plants origin that have shown antiviral activities were carried out on the two targets, 6lu7 and 6vsb by docking with the PyRx software. The binding affinities were compared with other compounds and drugs already identified as potential ligands for 6lu7 and 6vsb as well as Chloroquine and hydroxychloroquine. The docked compounds with best binding affinities were also filtered for drug likeness using the SwissADME and PROTOX platforms on the basis of Physicochemical properties and toxicity respectively. The docking results revealed that scopodulcic acid and dammarenolic acid had the best binding affinity on the s-glycoprotein and M pro protein targets respectively. Silybinin also demonstrated a good binding affinity to both protein targets making it a potential candidate for further evaluation as repurposed candidate for SARS COV2 with likelihood of having a multitarget activity.
17
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou, Xing‐Lou Yang, Xian-Guang Wang et al. · Nature · 2020 · 23.3K citations · Full text
Small-Molecule Library Screening by Docking with PyRx
Sargis Dallakyan, Arthur J. Olson · Methods in molecular biology · 2014 · 3.9K citations